Topical summits in Dubai, Berlin, Nanjing, Basel, Lisbon, London and other cities discussed the uniqueness of Dr Allen's ...

New prostate cancer drug showing ‘remarkable’ results during clinical trial - The new drug, known as VIR-5500, uses a ...

The new drug uses a so-called cloaking device and only activates when it reaches the tumour ...

Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical trial) procedures in Arizona using the Vanquish® Water ...

News, features, and commentary about cancer-related issues ...

Our immune system is great at fighting many types of cancer, but it struggles to see prostate tumors. While new treatments ...

NHS staff are going on tour to raise awareness of prostate cancer. The Humber and North Yorkshire Cancer Alliance (HNYCA) is ...

A “search and destroy” treatment has been found to halt tumours in some men with incurable prostate cancer. The early-stage ...

In the long term, stereotactic body radiotherapy carries a lower risk for biochemical failure vs high-dose rate brachytherapy for men with intermediate-risk prostate cancer.

HSHS St. Elizabeth’s Hospital is proud to announce the 100th Aquablation therapy procedure, marking a significant milestone ...

In recent months, a series of summits exploring new opportunities in life sciences and healthcare innovation have been held in the UK and China, including discussions on the impact of Thermobalancing ...

MARCAP investigators conducted the first individual patient data meta-analysis of randomized trials (POSEIDON) evaluating the use and duration hormone therapy with postoperative radiation therapy in ...